loading

Wound Care

Request a No-Obligation Consultation

Speak With Our Friendly and Knowledgable Team Today

Contact Us +

Advanced Wound Care for Non-Closing Wounds and Lesions

Dehydrated Human Amniotic Membrane Tissue Allograft

Has your wound care treatment stalled? Do they just scrape, repack and repeat with no hope for progress? What if we could offer you an FDA Medicare/Medicaid approved advanced wound CLOSING treatment? No more suffering.  No more painful treatments. No long term fear of potential amputation or aggressive and risky outcomes.  

Our proprietary wound closing membrane is a perinatal tissue-derived allograftcomposed of the amnion/chorion layer of the placentalmembrane. It is designated as a Human Cell, Tissue, andCellular and Tissue-Based Product (HCT/P) by the U.S.Food and Drug Administration (FDA), minimallymanipulated, and produced in accordance with the FDAregulations for Good Tissue Practices (21 CFR 1270, 1271) inour AATB® accredited lab.

Our wound closing membrane is intended for homologous use as aprotective covering for soft tissue wounds. It may be used in a variety of clinical contexts,consider confirming approved uses by reviewing yourLocal Coverage Determination (LCD). It is both FDA and Medicare/Medicaid approved.

Traditional Wound Treatment

Research has shown that if a wound has not healed by 53% within the first 30 days, it is unlikely to heal within 12 weeks. In fact, research has shown that between 55% and 70% of patients do not heal their wounds, according to Advances in Wound Care (2018).

Our Advanced Stem Cell Wound Closing Protocol!

Stem cell amniotic membranes have demonstrated wound closing in as little as 6 weeks.
Many people live in fear of debridement.  What if something could achieve biofilm disruption & stimulation of cell proliferation, without the need for debridement?

Innovative Wound Healing with Advanced Allograft Technology

Cutting-Edge Placental Membrane Therapy
Our proprietary wound-closing membrane is a state-of-the-art solution derived from perinatal tissue. Composed of the amnion/chorion layer of the placental membrane, this allograft offers exceptional regenerative properties to support healing in a variety of wound care applications. This advanced product is meticulously processed to preserve its natural biological components, making it an ideal option for patients with non-healing wounds. By leveraging the healing potential of placental tissue, our membrane is designed to optimize recovery and enhance patient outcomes.
FDA-Compliant and Produced to the Highest Standards
Designated as a Human Cell, Tissue, and Cellular and Tissue-Based Product (HCT/P) by the U.S. Food and Drug Administration (FDA), our wound-closing membrane is minimally manipulated to maintain its integrity and effectiveness. Produced in compliance with FDA regulations for Good Tissue Practices (21 CFR 1270, 1271), it is manufactured in our AATB®-accredited laboratory, ensuring the highest standards of quality and safety. This commitment to excellence provides peace of mind for patients and healthcare providers, reinforcing our dedication to delivering innovative and reliable wound care solutions.

We Can Treat A Wide Variety of Non-Healing Wounds

Care Covered under Medicare and Medicaid
As part of our commitment to accessibility of care, we welcome Medicare and Medicaid patients, making it easier for you to get the care you deserve. Trust our team to provide expert, compassionate care for your diabetic wound management.